Management thinks the company is on track for $500 million in revenue in 2020, but achieving that will require considerable capital investment.
The pharma announced first-quarter 2019 operating results.
Investors reacted with dismay over the terms of a license agreement.
The pharma company announced first-quarter 2019 operating results.
Revenue from the company's two drug products decreased 10% from the fourth quarter of 2018.
The biopharma announced first-quarter 2019 operating results.
The small-cap biotech now has three of the top 10 pharmaceutical companies using its protein engineering platform technology.
The pharma company got a rejection letter from the U.S. Food and Drug Administration.
The auto parts supplier reported first-quarter 2019 earnings.
The genetic testing leader and Wall Street weren't on the same page for first-quarter 2019 revenue.
These two companies are set to announce important business updates this month.
The diversified streaming company expects to see a surge in production. Can it erase the pain of a sour performance in 2018?
The women's health company reported first-quarter 2019 operating results.
Quarterly operating results were pretty good, but the business disclosed that it may face a lawsuit along with other makers of generic drugs.
The Chinese market has been a source of incredible growth for investors in recent years. Will ongoing economic turmoil challenge that?
The world's largest lithium producer could provide important updates about its long-term strategy.
The decision to retire $150 million in convertible debt caught the market off guard, but the business made progress on its long-term goals.
The business struggled with expected pricing challenges, but made progress on several long-term initiatives.
The ethanol producer needs to begin showing tangible signs of progress from its recent strategy shift.
The laboratory equipment manufacturer announced first-quarter 2019 operating results and a significant transaction.